BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 262275)

  • 1. [Use of hemofiltration in "difficult" uremic patients].
    Alloatti S; Grott G; Triolo G; Quarello F; Segoloni G; Marconetto M; Vercellone A; Piccoli G
    Minerva Nefrol; 1979; 26(3):359-64. PubMed ID: 262275
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultrafiltration without dialysis for removal of fluid and solutes in uremia.
    Bergström J
    Clin Nephrol; 1978 Apr; 9(4):156-64. PubMed ID: 648043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of carbohydrate metabolism after hemodialysis and hemofiltration in uremic patients.
    Geronemus R; Bosch JP; Thornton J; Rayfield EJ
    Arch Intern Med; 1982 Apr; 142(4):707-10. PubMed ID: 7041844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous hemofiltration/hemodialysis: an effective alternative to hemofiltration and conventional hemodialysis in the treatment of uremic patients.
    Leber HW; Wizemann V; Goubeaud G; Rawer P; Schütterle G
    Clin Nephrol; 1978 Mar; 9(3):115-21. PubMed ID: 639371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Techniques of continuous arteriovenous hemofiltration and hemodialysis. Renal replacement in the ICU for hypervolemic, uremic patients.
    Merrill RH
    J Crit Illn; 1991 Apr; 6(4):381-7. PubMed ID: 10147916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of different types of substitutive treatment on fibrinolytic potential of chronic uremic patients].
    Canavese C; Stratta P; Mangiarotti G; Triolo G; Bagnis C; Racca M; Vercellone A
    Minerva Nefrol; 1981; 28(3):339-43. PubMed ID: 7329613
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to rapid removal of intermediate molecular weight solutes in uremic man.
    Silverstein ME; Ford CA; Lysaght MJ; Henderson LW
    Trans Am Soc Artif Intern Organs; 1974; 20 B():614-21. PubMed ID: 4450311
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipid metabolism in hemofiltration. Comparison with the lipid pattern of hemodialyzed patients].
    Civati G; Galato R; Franceschini G; Guastoni C; Perego A; Minetti L
    Minerva Nefrol; 1980; 27(4):669-74. PubMed ID: 7254694
    [No Abstract]   [Full Text] [Related]  

  • 9. Technical requirements for rapid high-efficiency therapy in uremic patients. Paired filtration-dialysis (PFD) with a two-chamber technique.
    Ghezzi PM; Sanz-Moreno C; Gervasio R; Nigrelli S; Botella J
    ASAIO Trans; 1987; 33(3):546-50. PubMed ID: 3675986
    [No Abstract]   [Full Text] [Related]  

  • 10. [Isolated ultrafiltration and subsequent dialysis in overhydrated patients with chronic renal failure and hypertension].
    Szepietowski T; Abdulla K
    Pol Tyg Lek; 1988 Apr; 43(15):471-4. PubMed ID: 3405878
    [No Abstract]   [Full Text] [Related]  

  • 11. [The calcium-phosphorus balance and parathormone behavior in 7 patients treated with integral hemofiltration].
    Civati G; Guastoni C; Perego A; Galato R; Brando B; Grillo C; Surian M; Colussi G; Teatini U; Minetti L
    Minerva Nefrol; 1981; 28(2):171-4. PubMed ID: 7290521
    [No Abstract]   [Full Text] [Related]  

  • 12. Bicarbonate kinetics during biofiltration.
    Agazia B; Lombini C; Guarda L; Lorenzi S; Marchini P; Angoletta F; Saporiti E
    Kidney Int Suppl; 1988 Mar; 24():S120-2. PubMed ID: 3163032
    [No Abstract]   [Full Text] [Related]  

  • 13. Requirement of hemofiltration (HF) in uremic patients.
    Civati G; Guastoni C; Perego A; Teatini U; Minetti L
    Life Support Syst; 1983; 1 Suppl 1():282-8. PubMed ID: 6336430
    [No Abstract]   [Full Text] [Related]  

  • 14. [Substitutive treatment of the uremic diabetic. 8 years of experience and new prospects].
    Triolo G; Thea A; Carta Q; Stratta P; Vacha GM; Giorda G; Paola M; Segoloni GP; Piccoli G; Vercellone A
    Minerva Nefrol; 1981; 28(3):315-20. PubMed ID: 7329609
    [No Abstract]   [Full Text] [Related]  

  • 15. Removal of uremic toxins and regeneration of hemofiltrate by a selective dual hemofiltration artificial kidney (SEDUFARK) system.
    Jørstad S; Smeby LC; Widerøe TE; Berg KJ
    Clin Nephrol; 1980 Feb; 13(2):85-92. PubMed ID: 6988123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemofiltration in uremia: clinical approach].
    Vantelon J; Lauriat F; Perrone B; Jeannot F
    J Urol Nephrol (Paris); 1977 Sep; 83(9):712-7. PubMed ID: 926235
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dialysis treatment of chronic kidney insufficiency in the uremic phase. Indications and limitations].
    Garini G; Savazzi G; Arisi L
    Recenti Prog Med; 1986 Sep; 77(9):440-3. PubMed ID: 3797795
    [No Abstract]   [Full Text] [Related]  

  • 18. Ultrafiltration hemodynamics in conscious, uremic dogs: effect of using a bicarbonate-buffered, plasma-resembling dialysate.
    Daugirdas JT; Ing TS; Chen WT; Vestal RE; Izzo JL; Hano JE; Liu P
    Trans Am Soc Artif Intern Organs; 1982; 28():528-33. PubMed ID: 7164294
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcome of long-term hemofiltration.
    Baldamus CA; Quellhorst E
    Kidney Int Suppl; 1985 Dec; 17():S41-6. PubMed ID: 3912587
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alternative procedures in the therapy of chronic uremia (hemofiltration, continuing ambulatory peritoneal dialysis)].
    Scheler F
    Verh Dtsch Ges Inn Med; 1981; 87():1405-8. PubMed ID: 7331435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.